Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
NASDAQ:ALKS
Price:
23.86 USD
-0.62%
Market Closed
Updated:
May 3, 2024
Alkermes Plc
Cash from Financing Activities
|
Alkermes Plc
Cash from Financing Activities Peer Comparison
Comparables:
AMRN
PRTA
M
MURA
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Alkermes Plc
NASDAQ:ALKS
|
Cash from Financing Activities
-$289.7m
|
CAGR 3-Years
-409%
|
CAGR 5-Years
-183%
|
CAGR 10-Years
N/A
|
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Cash from Financing Activities
$230k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-76%
|
CAGR 10-Years
-47%
|
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Cash from Financing Activities
$45.1m
|
CAGR 3-Years
490%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-6%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Cash from Financing Activities
$468.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Cash from Financing Activities?
Cash from Financing Activities
-289.7m
USD
-289.7m
USD
Based on the financial report for Dec 31, 2023, Alkermes Plc's Cash from Financing Activities amounts to -289.7m USD.
What is Alkermes Plc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-183%
-183%
Over the last year, the Cash from Financing Activities growth was -18 007%. The average annual Cash from Financing Activities growth rates for Alkermes Plc have been -409% over the past three years , -183% over the past five years .
You don't have any saved screeners yet
